AstraZeneca AB (manufacturing, testing, primary packaging, release of unpackaged medicinal product, secondary packaging and release of finished medicinal product)

The drug is used for the treatment of gastroesophageal reflux disease (GERD), esophagitis, gastric ulcers (including those caused by anti-inflammatory drugs), and for the prevention of recurrent bleeding after endoscopic treatment of ulcers.

Dosage form: powder for solution for injection and infusion

ATC: A02BC05